date:Nov 21, 2018
tions that will help the FDA continue to enhance our nationwide post-market surveillance system; address new safety concerns that emerge once a device is on the market; and encourage innovations that lead to safer medical devices.
Today, were focusing on several key actions were taking to create a more robust medical device safety net for patients through better data. Were also announcing several new steps related to important health devices that impact women, including surgical mesh for transva